1 year return (CAGR)
78.53%
United Therapeutics Corporation Exchange (NASDAQ, USD)
UTHR
500.35
-8.66 (-1.52%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
37.00%
5 year return (CAGR)
24.08%
10 year return (CAGR)
17.46%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
23.85B
Price/Sales
7.49
Ent value
23.08B
Price/Book
3.36
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
17.87
PEG
-
Forward P/E
17.06
EPS growth
19.31%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 571.27 |
| Daily high | 574.00 |
| Daily low | 560.15 |
| Daily Volume | 514K |
| All-time high | 596.76 |
| 1y analyst estimate | 664.33 |
| Beta | 0.56 |
| EPS (TTM) | 28.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| UTHR | S&P500 | |
| Current price drop from All-time high | -16.16% | -2.63% |
| Highest price drop | -93.18% | -56.47% |
| Date of highest drop | 10 Dec 2001 | 9 Mar 2009 |
| Avg drop from high | -35.32% | -10.69% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 2634 days | 1805 days |
News
